M&A / Deals Syneron raises $150m for macrocyclics, and other financings PharmaphorumOur round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.M&A / DealsRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder. M&A / DealsRead full story Post navigation Previous: Shionogi secures $482m BARDA contract to tackle AMR crisisNext: FDA seeks permanent future for rare pediatric priority review vouchers Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
